Jan 2, 2001 (CIDRAP News) Aside from Capitol Hill staff members, only 52 of more than 3,500 people who have been offered the anthrax vaccine because of the recent mail attacks have decided to take it, according to the Centers for Disease Control and Prevention (CDC).
(CIDRAP News) – A new nuclear medicine technique using a radioisotope-labeled antibody has shown enough promise for early diagnosis of anthrax infection to gain the Food and Drug Administration's approval for a clinical trial, according to a recent report in the Journal of Nuclear Medicine.
(CIDRAP News) A recent analysis of ground pork in grocery stores in five states showed that 4% of the samples contained enterococci with high-level resistance to gentamicin, an antibiotic used to treat enterococcal infections in humans. In addition, most Enterococcus faecium isolates were resistant to quinupristin-dalfopristin (Synercid), a streptogramin antibiotic used to treat infections caused by vancomycin-resistant E faecium.
(CIDRAP News) Federal health officials revealed this week that they are working on a plan to use immune globulin derived from the blood of anthrax-vaccinated military personnel for emergency treatment of patients with severe cases of inhalational anthrax, if needed.
(CIDRAP News) Thousands of people who were potentially exposed to anthrax last fall will be interviewed over the next 8 weeks to assess the results of their postexposure antibiotic treatment, the Centers for Disease Control and Prevention (CDC) announced yesterday.
(CIDRAP News) The US Department of Health and Human Services (HHS) will soon release about 20% of the $1 billion in bioterrorism preparedness funding that is slated to go to states this year, HHS Secretary Tommy G. Thompson announced Jan 25.
(CIDRAP News) The proposed 2003 budget for the US Department of Health and Human Services (HHS) features a 45% increase in spending for bioterrorism preparedness, with research at the National Institutes of Health (NIH) accounting for much of the increase.
(CIDRAP News) The Centers for Disease Control and Prevention (CDC) says it will take several months to determine if women in the US military who received anthrax vaccine in the first trimester of pregnancy had a greater risk of bearing children with birth defects.
(CIDRAP News) There is no complete fix for the problem of foodborne illness, but a comprehensive, farm-to-table approach with specific targets for limiting pathogenic contamination would improve food safety, according to a new report by the Institute of Food Technologists (IFT).
(CIDRAP News) A committee of the Institute of Medicine (IOM) has concluded after 17 months of study that the existing anthrax vaccine is effective and "acceptably safe," but a new vaccine that requires fewer doses and that causes fewer reactions is needed.